BioScience Health Innovations, Inc. (BHICD)

BHICD Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.3	0.66	0.02	0.01	0
Cash & Short-Term Investments	1.3	0.66	0.02	0.01	0
Cash Growth	802.85%	3343.79%	66.29%	11469.00%	-
Accounts Receivable	0.39	0.1	0.04	0.01	-
Other Receivables	-	0.02	-	-	-
Receivables	0.39	0.12	0.04	0.01	-
Inventory	0.25	0.06	0.04	0.01	-
Prepaid Expenses	0.05	0	-	-	-
Total Current Assets	1.99	0.85	0.09	0.03	0
Other Intangible Assets	0.07	0.03	-	-	-
Total Assets	2.06	0.87	0.09	0.03	0
Accounts Payable	0.02	0.01	0.01	0	-
Accrued Expenses	0.02	0.01	0	-	-
Short-Term Debt	0.05	-	0.09	0.05	0
Current Unearned Revenue	0.25	0.02	0	-	-
Total Current Liabilities	0.34	0.04	0.1	0.05	0
Total Liabilities	0.34	0.04	0.1	0.05	0
Common Stock	0	0	0	0.01	0.01
Additional Paid-In Capital	1.17	1.17	0.42	0.15	-
Retained Earnings	0.54	-0.34	-0.43	-0.18	-0.01
Total Common Equity	1.72	0.84	-0.01	-0.02	-0
Shareholders' Equity	1.72	0.84	-0.01	-0.02	-0
Total Liabilities & Equity	2.06	0.87	0.09	0.03	0
Total Debt	0.05	-	0.09	0.05	0
Net Cash (Debt)	1.25	0.66	-0.07	-0.03	-0
Net Cash Per Share	0.03	0.02	-0.00	-0.00	-0.00
Filing Date Shares Outstanding	43.92	43.92	41.6	5.46	3.4
Total Common Shares Outstanding	43.92	43.92	41.6	9.68	3.4
Working Capital	1.65	0.81	-0.01	-0.02	-0
Book Value Per Share	0.04	0.02	-0.00	-0.00	-0.00
Tangible Book Value	1.65	0.81	-0.01	-0.02	-0
Tangible Book Value Per Share	0.04	0.02	-0.00	-0.00	-0.00

Source: S&P Global Market Intelligence. Standard template. Financial Sources.